| pubmed-article:12385442 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12385442 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12385442 | lifeskim:mentions | umls-concept:C0009324 | lld:lifeskim |
| pubmed-article:12385442 | lifeskim:mentions | umls-concept:C0281481 | lld:lifeskim |
| pubmed-article:12385442 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:12385442 | pubmed:dateCreated | 2002-10-18 | lld:pubmed |
| pubmed-article:12385442 | pubmed:abstractText | Tumor necrosis factor-alpha (TNF-alpha) is an important cytokine involved in the pathogenesis of inflammatory bowel disease. The monoclonal antibody to TNF-alpha, infliximab, is effective in treating Crohn's disease. Preclinical studies suggest the importance of TNF-alpha in treating ulcerative colitis (UC). We report the effectiveness of infliximab for UC and examine factors predictive of response to medication. | lld:pubmed |
| pubmed-article:12385442 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12385442 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12385442 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12385442 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12385442 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12385442 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12385442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12385442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12385442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12385442 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12385442 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:12385442 | pubmed:issn | 0002-9270 | lld:pubmed |
| pubmed-article:12385442 | pubmed:author | pubmed-author:StaddonS LSL | lld:pubmed |
| pubmed-article:12385442 | pubmed:author | pubmed-author:SteinRobert... | lld:pubmed |
| pubmed-article:12385442 | pubmed:author | pubmed-author:LichtensteinG... | lld:pubmed |
| pubmed-article:12385442 | pubmed:author | pubmed-author:KatzkaDavid... | lld:pubmed |
| pubmed-article:12385442 | pubmed:author | pubmed-author:SuChinyuC | lld:pubmed |
| pubmed-article:12385442 | pubmed:author | pubmed-author:SalzbergBruce... | lld:pubmed |
| pubmed-article:12385442 | pubmed:author | pubmed-author:DerenJulius... | lld:pubmed |
| pubmed-article:12385442 | pubmed:author | pubmed-author:KornbluthAshe... | lld:pubmed |
| pubmed-article:12385442 | pubmed:author | pubmed-author:AdlerDouglas... | lld:pubmed |
| pubmed-article:12385442 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12385442 | pubmed:volume | 97 | lld:pubmed |
| pubmed-article:12385442 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12385442 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12385442 | pubmed:pagination | 2577-84 | lld:pubmed |
| pubmed-article:12385442 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:meshHeading | pubmed-meshheading:12385442... | lld:pubmed |
| pubmed-article:12385442 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12385442 | pubmed:articleTitle | Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis. | lld:pubmed |
| pubmed-article:12385442 | pubmed:affiliation | Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104-4283, USA. | lld:pubmed |
| pubmed-article:12385442 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12385442 | lld:pubmed |
